Biotechnology and genomic technologies
ESOF session Privacy in the genomic era – A reality check, Copenhagen, 23 June 2014
Visit the conference website for more information.
EMBO | EMBL Science & Society conference Personal and Public Health – Genomics, Medicine and Society, 7-8 November 2013
The 14th conference in the Science & Society conference series focussed on how the use of genomic information may benefit individual and public health. The conference speakers presented the status of genetic and genomic research and discussed the ethical, legal, economic and societal implications as well as the practical challenges of implementing the new knowledge into medical care. Visit the conference website for further details.
ESF-supported Workshop on the Biological Containment of Synthetic Microorganisms: Science and Policy, 13-14 November 2012, EMBL, Heidelberg
This by-invitation workshop focussed on the containment of synthetic microorganisms and addressed three major questions: First, what potential risks to the environment are presented by the intentional release of genetically synthetic microorganisms? Second, what mechanisms can be employed to control these microorganisms in the environment? Finally, what are the parameters for risk assessment of these novel microorganisms?
The international and interdisciplinary experts evaluated current knowledge and identify research needs in these areas for science and policy. Biological control is an emerging issue in Europe and this meeting started discussions between experts and stakeholders.
Download workshop report
An international group of leading stem cell researchers has issued a statement that specifies concerns about the development and use of unproven stem cell therapies. The commentary is published online in The EMBO Journal ahead of a debate in the Italian parliament on whether to change a recent law that allows certain untested stem cell therapies to be used by the public health system. Read the paper: doi: 10.1038/emboj.2013.114
T. +49 6221 8891 552
T. + 49 6221 8891 119